However, data from TCGA showed that EMP2 overexpression was associated with favorable prognosis in patients with lung cancer (https://www.proteinatlas.org/ENSG00000213853-EMP2/pathology/lung+cancer#imid_3898442) (accessed on: 13 March 2021). This evidence concerns the gene EMP2 and lung cancer.